Stock SCOL SCANDION ONCOLOGY A/S
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Scandion Oncology A/S

Equities

SCOL

DK0061031895

Delayed Nasdaq Stockholm
Other stock markets
 11:24:01 2024-06-05 am EDT 		5-day change 1st Jan Change
0.498 SEK -20.95% Intraday chart for Scandion Oncology A/S -25.00% -87.53%
May. 22 Transcript : Scandion Oncology A/S, Q1 2024 Earnings Call, May 22, 2024
May. 22 Scandion Oncology A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SCANDION ONCOLOGY A/S Stock Scandion Oncology A/S
 1.95M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 109B
BIONTECH SE Stock BioNTech SE
 24.74B -
ARGENX SE Stock argenx SE
 22.67B -
GENMAB A/S Stock Genmab A/S
 18.14B
  1. Stock Market
  2. Equities
  3. SCOL Stock
  4. Charts Scandion Oncology A/S
  5. Sector Chart